A Prospective Multicenter Non-randomized Controlled Study of Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma

Trial Profile

A Prospective Multicenter Non-randomized Controlled Study of Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Apr 2016

At a glance

  • Drugs Sorafenib (Primary) ; Antineoplastics
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Acronyms 2011PTAHCC
  • Most Recent Events

    • 13 Apr 2016 Planned End Date changed from 1 Jan 2016 to 1 Jan 2017.
    • 04 Oct 2012 Planned end date changed from 1 Jan 2013 to 1 Jan 2016 as reported by ClinicalTrials.gov record.
    • 09 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top